Want to see JP:3927 full AI Analyst Report?

Fuva Brain Ltd. (3927) Price & Analysis

0 Followers

3927 Stock Chart & Stats

¥810.00

-¥1.00(-0.15%)

At close: Jan 08 4:00 PM EST

¥810.00

-¥1.00(-0.15%)

Day’s Range― - ―

52-Week Range¥696.00 - ¥1,280.00

Previous CloseN/A

Volume26.10K

Average Volume (3M)98.91K

Market Cap

¥5.13B

Enterprise Value¥3.96B

Total Cash (Recent Filing)¥1.93B

Total Debt (Recent Filing)¥541.30M

Price to Earnings (P/E)16.6

Beta1.14

Next Earnings

Aug 07, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)67.08

Shares Outstanding5,604,200

10 Day Avg. Volume142,280

30 Day Avg. Volume98,910

Financial Highlights & Ratios

PEG Ratio0.12

Price to Book (P/B)2.97

Price to Sales (P/S)1.13

P/FCF Ratio29.80

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthSustained double-digit revenue expansion demonstrates durable product-market fit and expanding customer adoption. Over a 2–6 month horizon, persistent top-line momentum supports reinvestment in product and sales capacity, reduces per-unit fixed costs as scale grows, and underpins longer-term margin recovery initiatives.

ROE & Profitability RecoveryA meaningful ROE rebound indicates management is converting capital into higher returns, reflecting improved profitability and operational leverage. This recovery suggests the company can generate shareholder value and fund growth internally, improving resilience and strategic optionality over the medium term.

Positive Free Cash FlowCurrent positive FCF shows the business is starting to convert earnings into real cash available for debt paydown, reinvestment, or dividends. Even if earlier years were weaker, sustained FCF at this level would support capex, product investment and lower dependence on external financing across the next several quarters.

Bears Say

Gross Margin CompressionA sharp, structural decline in gross margins erodes the company's core profitability and limits operating leverage. If lower margins reflect pricing pressure or rising delivery costs, it reduces the buffer against slower revenue growth and makes sustained operating margin improvement harder without material cost or pricing changes.

Rising LeverageIncreased reliance on debt to fund growth raises financial fixed costs and reduces balance sheet flexibility. Higher leverage magnifies downside risk if growth or margins falter and can constrain strategic investments or add refinancing risk over the next several quarters, particularly in a rising-rate environment.

Volatile Cash ConversionInconsistent operating cash flow history undermines confidence in the durability of reported profits and hampers planning. Persistent volatility forces greater working capital scrutiny, may necessitate external financing during troughs, and weakens the sustainability of dividends or buybacks absent steadier conversion.

3927 FAQ

What was Fuva Brain Ltd.’s price range in the past 12 months?

Fuva Brain Ltd. lowest stock price was ¥696.00 and its highest was ¥1280.00 in the past 12 months.

What is Fuva Brain Ltd.’s market cap?

Fuva Brain Ltd.’s market cap is ¥5.13B.

When is Fuva Brain Ltd.’s upcoming earnings report date?

Fuva Brain Ltd.’s upcoming earnings report date is Aug 07, 2026 which is in 38 days.

How were Fuva Brain Ltd.’s earnings last quarter?

Fuva Brain Ltd. released its earnings results on May 15, 2026. The company reported -¥4.68 earnings per share for the quarter, missing the consensus estimate of N/A by -¥4.68.

Is Fuva Brain Ltd. overvalued?

According to Wall Street analysts Fuva Brain Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Fuva Brain Ltd. pay dividends?

Fuva Brain Ltd. pays a Notavailable dividend of ¥7.937 which represents an annual dividend yield of N/A. See more information on Fuva Brain Ltd. dividends here

What is Fuva Brain Ltd.’s EPS estimate?

Fuva Brain Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Fuva Brain Ltd. have?

Fuva Brain Ltd. has 5,604,200 shares outstanding.

What happened to Fuva Brain Ltd.’s price movement after its last earnings report?

Fuva Brain Ltd. reported an EPS of -¥4.68 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.794%.

Which hedge fund is a major shareholder of Fuva Brain Ltd.?

Currently, no hedge funds are holding shares in JP:3927

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Fuva Brain Ltd.

Fuva Brain Limited, headquartered in Tokyo, Japan, has been providing cybersecurity solutions since its incorporation in 2001 (initially as Ahkun Co., Ltd. until its name change in October 2018). The company's diverse range of offerings for the Japanese market includes solutions for gateway network defense, endpoint security, internal fraud prevention, and productivity enhancement. Among its key products are "Eye 247 Work Smart," which supports business visualization and protects against information leakage, and "Eye 247 Work Smart Server," a dedicated file server tailored for small and medium-sized businesses. For advanced threat protection, they offer "Eye 247 AntiMalware," designed to combat known, emerging, and entirely new digital threats. Additionally, Fuva Brain provides "SecureSphere" for integrated security across web applications and database servers, and "Incapsula" for comprehensive cloud-based web security.